Technical Analysis for ABVX - ABIVAX Société Anonyme
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 8.86 | -0.56% | -0.05 |
ABVX closed down 0.56 percent on Wednesday, November 20, 2024, on 25 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Hammer Candlestick | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | about 20 hours ago |
| Down 2 % | about 20 hours ago |
| Down 1% | about 20 hours ago |
| New 52 Week Low | about 20 hours ago |
| Down 3% | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Autoimmune Disease Inflammatory Bowel Disease Ulcerative Colitis Gastroenterology Colitis Diarrhea
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Autoimmune Disease Inflammatory Bowel Disease Ulcerative Colitis Gastroenterology Colitis Diarrhea
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.02 |
| 52 Week Low | 8.69 |
| Average Volume | 125,945 |
| 200-Day Moving Average | 12.66 |
| 50-Day Moving Average | 10.41 |
| 20-Day Moving Average | 10.14 |
| 10-Day Moving Average | 9.84 |
| Average True Range | 0.42 |
| RSI (14) | 27.54 |
| ADX | 21.26 |
| +DI | 17.93 |
| -DI | 32.61 |
| Chandelier Exit (Long, 3 ATRs) | 9.77 |
| Chandelier Exit (Short, 3 ATRs) | 9.94 |
| Upper Bollinger Bands | 11.25 |
| Lower Bollinger Band | 9.03 |
| Percent B (%b) | -0.08 |
| BandWidth | 21.91 |
| MACD Line | -0.34 |
| MACD Signal Line | -0.18 |
| MACD Histogram | -0.1603 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.19 | ||||
| Resistance 3 (R3) | 9.17 | 9.04 | 9.14 | ||
| Resistance 2 (R2) | 9.04 | 8.96 | 9.05 | 9.12 | |
| Resistance 1 (R1) | 8.95 | 8.90 | 8.89 | 8.97 | 9.10 |
| Pivot Point | 8.82 | 8.82 | 8.79 | 8.83 | 8.82 |
| Support 1 (S1) | 8.73 | 8.74 | 8.67 | 8.75 | 8.62 |
| Support 2 (S2) | 8.60 | 8.68 | 8.61 | 8.60 | |
| Support 3 (S3) | 8.51 | 8.60 | 8.59 | ||
| Support 4 (S4) | 8.53 |
